Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Gains from Sales and Divestitures: 2022

Historic Gains from Sales and Divestitures for Therapeutics (LENZ) over the last 1 years, with Dec 2022 value amounting to $553,443.

  • Therapeutics' Gains from Sales and Divestitures rose 40.00% to $703,035 in Q3 2023 from the same period last year, while for Sep 2023 it was $703,035, marking a year-over-year increase of 40.00%. This contributed to the annual value of $553,443 for FY2022, which is N/A change from last year.
  • As of FY2022, Therapeutics' Gains from Sales and Divestitures stood at $553,443.
  • Over the past 5 years, Therapeutics' Gains from Sales and Divestitures peaked at $553,443 during FY2022, and registered a low of $553,443 during FY2022.
  • Over the past 1 years, Therapeutics' median Gains from Sales and Divestitures value was $553,443 (recorded in 2022), while the average stood at $553,443.